Browse
Submit Data
Databases
API
Help

Dataset Information

11 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines.

ABSTRACT: Major histocompatibility complexes (MHC) play a critical role in immunity by presenting peptides on the cell surface for T cell recognition. Identification of these peptides can be valuable to develop vaccines or immunotherapeutic strategies for infectious diseases and cancers. Mass spectrometry is the only tool available for unbiased identification of the immunopeptidome. Here, we describe a protocol for purification and identification of MHC class I peptides, including in-house purification of anti-MHC-antibody from hybridoma cells and the LC-MS/MS analysis of MHC-I bound peptides.

SUBMITTER: Mohan SV

PROVIDER: S-EPMC7982746 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Variations in MHC class I antigen presentation and immunopeptidome selection pathways.

Project description: Not available

| S-EPMC7525337 | biostudies-literature

A tissue-based draft map of the murine MHC class I immunopeptidome.

Project description: Not available

| S-EPMC6080492 | biostudies-literature

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome.

Project description: Not available

| S-EPMC6350689 | biostudies-literature

The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis.

Project description: Not available

| S-EPMC5557335 | biostudies-literature

MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.

Project description: Not available

| S-EPMC5999401 | biostudies-literature

Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancer

Project description:Tumor epitopes – peptides that are presented on surface-bound MHC I proteins - provide targets for cancer immunotherapy and have been identified extensively in the annotated protein-coding regions of the genome. Motivated by the recent discovery of translated novel unannotated open reading frames (nuORFs) using ribosome profiling (Ribo-seq), we hypothesized that cancer-associated processes could generate nuORFs that can serve as a new source of tumor antigens that harbor somatic mutations or show tumor-specific expression. To identify cancer-specific nuORFs, we generated Ribo-seq profiles for 29 malignant and healthy samples. These included primary normal and chronic lymphocytic leukemia (CLL) B cells, patient-derived primary glioblastoma (GBM) and melanoma cell cultures, primary healthy melanocytes, as well as established colon carcinoma and melanoma cell lines. These also included B721.221 cells, the parental cell line previously used to generate 92 single HLA allele-expressing lines from which we collected mono-allelic MHC I immunopeptidome data. We developed a hierarchical approach to identify translated novel unannotated open reading frames that leverages the large amount of Ribo-seq data we have generated in order to uncover lowly expressed nuORFs, while also preserving tissue specificity. We constructed a database of novel unannotated ORFs (nuORFdb) and used it to analyze mass spectrometry datasets of MHC I-bound peptides, where we detected peptides from 3,555 nuORFs. Additionally, we used nuORFdb to identify cancer-specific nuORFs, as well as nuORFs harboring cancer-specific somatic variants as potential sources of neoantigens in cancer. *This repository contains data from the publicly available cell lines used in this study, including B721.221 cells, A375 cells, HCT116 cells and primary healthy melanocytes (Thermo C0025C). The data pertaining to primary patient samples that are part of this study is deposited in dbGaP.

2020-08-01 | GSE143263 | GEO

Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome.

Project description: Not available

| S-EPMC7786382 | biostudies-literature

Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy.

Project description: Not available

| S-EPMC1595446 | biostudies-literature

Critical Review of Existing MHC I Immunopeptidome Isolation Methods.

Project description: Not available

| S-EPMC7699222 | biostudies-literature

An input-controlled model system for identification of MHC bound peptides enabling laboratory comparisons of immunopeptidome experiments.

Project description: Not available